Author:
Roberts David,Brunskill Susan,Doree Carolyn,Williams Senani,Howard Jo,Hyde Chris
Reference115 articles.
1. Randomised, prospective evaluation of iron balance, chelation efficiency, urine excretion and NTBI progression with deferiprone (DFP) or deferoxamine (DFO) monotherapy or with combined DFP plus DFO [abstract];Aydinok;Blood,2005
2. Urinary iron excretion depends on the mode of administration of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one in patients with homozygous beta-thalassaemia;Fassos;Clinical Pharmacology and Therapeutics,1994
3. Comparative efficacy of desferrioxamine, deferiprone and in combination on iron chelation in thalassaemic children;Gomber;Indian Paediatrics,2004
4. A randomised controlled study evaluating the safety and efficacy of deferiprone treatment in thalassaemia major patients from Hong Kong;Ha;Hemoglobin,2006
5. A randomised controlled study evaluating the safety and efficacy of deferiprone treatment in thalassaemia major patients from Hong Kong;Ha;Hemoglobin,2006
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献